Lynparza gets positive opinion from EU CHMP as adjuvant treatment for germline BRCA-mutated early breast cancer
First and only PARP inhibitor to improve invasive disease-free survival in patients
First and only PARP inhibitor to improve invasive disease-free survival in patients
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated